Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Intravitreal Bevacizumab Before PRP in Diabetic Retinopathy
NCT01504724Phase 4Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Aug 2011
- Primary completion
- Aug 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in diabetic retinopathy (DR), sponsored by Kyungpook National University Hospital. Started Aug 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT01504724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504724.